Monopar Therapeutics

NORTHBROOK, IL · Founded 2014 · CIK 0001645469 · Biotech · Private

Targeted small-molecule therapeutics for Wilson Disease and cancer

monopartx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$2.1M
4 Form D · Aug 2017
110 months since last filing
Contracts
—
No federal contracts on record
Patents
13
2 granted · 11 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,105,100
Private capital raisedForm D · SEC$3,000,000
Private capital raisedForm D · SEC$10,000,000
Private capital raisedForm D · SEC$4,500,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1377Vcreate, Inc.——
1378YASO THERAPEUTICS INCORPORATED——
1379CHIMERNA THERAPEUTICS, INC.——
1380Monopar Therapeutics—$2.1M
1381INFLAMED, INC.——
1382XPOSE THERAPEUTICS, INC.——
1383REJUVENATION TECHNOLOGIES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Raymond AndersonDirector
  • Michael BrownDirector
  • Andrew MazarDirector · Executive Officer
  • Chandler RobinsonDirector · Executive Officer · Promoter
  • Christopher StarrDirector · Executive Officer

Patents

USPTO · 2 granted of 13
  • Materials And Methods For Treating Coronavirusapplication
  • Urokinase Plasminogen Activator Receptor-Targeted Radiopharmaceuticalapplication
  • Trivalent Radioisotope Bio-Targeted Radiopharmaceutical, Methods Of Preparation And Useapplication
  • Clonidine And/or Clonidine Derivatives For Use In The Prevention Of Skin Injury Resulting From Radiotherapygranted
  • 3'-DEAMINO-3'-(2"-PYRROLINE-1"-YL)-5-IMINO-13-DEOXYANTHRACYCLINES And Methods Of Preparationgranted
  • Trivalent Radioisotope Bio-targeted Radiopharmaceutical, Methods Of Preparation And Useapplication
  • Antibody Radioisotope Constructsapplication
  • Urokinase Plasminogen Activator Receptor-targeted Radiopharmaceuticalapplication
  • Precision Radioimmunotherapeutic Targeting Of The Urokinase Plasminogen Activartor Receptor (upar) For Treatment Of Severe COVID-19 Diseaseapplication
  • Precision Radioimmunotherapeutic Targeting of the Urokinase Plasminogen Activator Receptor (uPAR) for Treatment of Severe COVID-19 Diseaseapplication
  • 3'DEAMINO-3'-(2'-PYRROLINE-1"YL)-5-IMINO-13-DEOXYANTHRACYCLINES And Methods Of Preparationapplication
  • Squaramide Bi-Functional Chelators and Associated Radiopharmaceuticals and Methods of Useapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.